The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  2016-07-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00228-016-2095-0PMID 27439448
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of the selected cytochrome P450 oxidoreductase genetic polymorphisms on cytochrome P450 2B6 activity as measured by bupropion hydroxylation

  2016cited by this paper
• Combination bupropion SR and varenicline for smoking cessation: a systematic review

  2016cited by this paper
• The Accompanying Changes in Brain Structure of a Remitted Depression Patient with the Bupropion Treatment

  2015cited by this paper
• P450 Oxidoreductase *28 (POR*28) and Tacrolimus Disposition in Pediatric Kidney Transplant Recipients—A Pilot Study

  2014cited by this paper
• The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients

  2014cited by this paper
• Effects of CYP2B6 genetic polymorphisms in patients receiving cyclophosphamide combination chemotherapy for breast cancer

  2014cited by this paper
• POR*28 SNP is associated with lipid response to atorvastatin in children and adolescents with familial hypercholesterolemia.

  2014cited by this paper
• Allyl isothiocyanate (AITC) inhibits pregnane X receptor (PXR) and constitutive androstane receptor (CAR) activation and protects against acetaminophen- and amiodarone-induced cytotoxicity

  2014cited by this paper
• Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance

  2013cited by this paper
• Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin

  2013cited by this paper
• Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate

  2013cited by this paper
• Influence of CYP2B6 genetic variants on plasma and urine concentrations of bupropion and metabolites at steady state

  2013cited by this paper
• Cytochrome P450 oxidoreductase genetic polymorphisms A503V and rs2868177 do not significantly affect warfarin stable dosage in Han-Chinese patients with mechanical heart valve replacement

  2013cited by this paper
• Worldwide variation in human drug-metabolism enzyme genes CYP2B6 and UGT2B7: implications for HIV/AIDS treatment.

  2012cited by this paper
• Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6

  2012cited by this paper
• Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men.

  2011cited by this paper
• Identification of Cytochrome P450 Oxidoreductase Gene Variants That Are Significantly Associated with the Interindividual Variations in Warfarin Maintenance Dose

  2011cited by this paper
• Effects of Pregnane X Receptor (NR1I2) and CYP2B6 Genetic Polymorphisms on the Induction of Bupropion Hydroxylation by Rifampin

  2011cited by this paper
• Transcriptional regulation of the human P450 oxidoreductase gene: hormonal regulation and influence of promoter polymorphisms.

  2011cited by this paper
• Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex

  2011cited by this paper
• The P450 oxidoreductase *28 SNP is associated with low initial tacrolimus exposure and increased dose requirements in CYP3A5-expressing renal recipients.

  2011cited by this paper
• Substrate-specific modulation of CYP3A4 activity by genetic variants of cytochrome P450 oxidoreductase

  2010cited by this paper
• PharmGKB summary: very important pharmacogene information for CYP2B6

  2010cited by this paper
• Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro

  2010cited by this paper
• Human hepatic CYP2B6 developmental expression: the impact of age and genotype.

  2009cited by this paper
• Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation.

  2009cited by this paper
• Genetic polymorphisms in cytochrome P450 oxidoreductase influence microsomal P450-catalyzed drug metabolism

  2008cited by this paper
• Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations

  2008cited by this paper
• CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.

  2008cited by this paper
• Polymorphic CYP2B6: molecular mechanisms and emerging clinical significance.

  2007cited by this paper
• CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial.

  2007cited by this paper
• Cytochrome P450 2B6 activity as measured by bupropion hydroxylation: Effect of induction by rifampin and ethnicity

  2006cited by this paper
• Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

  2004cited by this paper
• Identification of Novel Roles of the Cytochrome P450 System in Early Embryogenesis: Effects on Vasculogenesis and Retinoic Acid Homeostasis

  2003cited by this paper
• Hepatic CYP2B6 Expression: Gender and Ethnic Differences and Relationship to CYP2B6 Genotype and CAR (Constitutive Androstane Receptor) Expression

  2003cited by this paper
• Inactivation of the Hepatic Cytochrome P450 System by Conditional Deletion of Hepatic Cytochrome P450 Reductase*

  2003cited by this paper
• Cytochrome P-450 2B6 Is Responsible for Interindividual Variability of Propofol Hydroxylation by Human Liver Microsomes

  2001cited by this paper
• Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.

  2001cited by this paper
• Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver.

  2001cited by this paper
• Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.

  2000cited by this paper
• CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.

  2000cited by this paper
• Identification of the human cytochrome P450 enzymes involved in the in vitro metabolism of artemisinin.

  1999cited by this paper
• A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.

  1998cited by this paper
• Thyroid regulation of NADPH:cytochrome P450 oxidoreductase: identification of a thyroid-responsive element in the 5'-flank of the oxidoreductase gene.

  1997cited by this paper
• Studies on the rate of reduction of hepatic microsomal cytochrome P-450 by reduced nicotinamide adenine dinucleotide phosphate: effect of drug substrates.

  1969cited by this paper

• Pharmacogenetic influence on bupropion bioactivation and clinical outcomes in major depressive disorder.

  2026cites this paper
• Pharmacogenomic Profiling of Frequently Prescribed Medications Among Geriatric Patients in a Tertiary Care Setting in Southwestern India

  2025cites this paper
• Pharmacogenetic Influence on Stereoselective Steady-State Disposition of Bupropion

  2024influential citation
• Effects of rifampicin, CYP2B6 and ABCB1 polymorphisms on efavirenz plasma concentration in Chinese patients living with HIV and tuberculosis

  2022cites this paper
• Methadone pharmacogenetics in vitro and in vivo: Metabolism by CYP2B6 polymorphic variants and genetic variability in paediatric disposition

  2022cites this paper
• PGPM_A_274741 117..133

  2021cites this paper
• Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon

  2021cites this paper
• Physiologically Based Pharmacokinetic Modeling of Bupropion and Its Metabolites in a CYP2B6 Drug-Drug-Gene Interaction Network

  2021cites this paper
• Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis

  2021cites this paper
• Stereoselective Bupropion Hydroxylation by Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase Genetic Variants

  2020cites this paper
• Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition

  2018influential citation
• Cytochrome P450 oxidoreductase genetic polymorphism and pantoprazole pharmacokinetics in healthy volunteers

  2018cites this paper
• Stereoselective Ketamine Metabolism by Genetic Variants of Cytochrome P450 CYP2B6 and Cytochrome P450 Oxidoreductase

  2018cites this paper